This inventor holds 20 USPTO granted patents and 36 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Molecular Profiling. Top assignees: Caris Mpi, Inc., The Translational Genomics Research Institute, The University of Arizona. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Phoenix, AZ (US) (2014)
- Scottsdale, AZ (US) (2013 - 2019)
Company Filing History:
17 out of 22 
3 out of 124 
1 out of 1,060 Years Active: 2013-2026
Areas of Expertise:
Title: Innovations and Contributions of Daniel D. Von Hoff: A Pioneer in Cancer Treatment
Introduction: Daniel D. Von Hoff is a distinguished inventor and researcher based in Phoenix, AZ, recognized for his substantial contributions in the field of cancer treatment. With an impressive portfolio of 17 patents, his work has significantly advanced the understanding and treatment of various cancers, particularly those resistant to existing therapies.
Latest Patents: Among his latest innovations, Daniel has developed methods and kits aimed at predicting therapeutic outcomes for patients using BTK inhibitors. These include methods that assess the expression of DPC4 (SMAD4) to identify individuals with pancreatic cancer who are likely to respond or not respond to treatment. His patents outline a range of methods for treating subjects based on these assessments, therapeutic targets for cancers with inactivated DPC4 genes, and pharmaceutical compositions, such as BTK inhibitors like PCI-32765. Additionally, he has introduced methods and systems for molecular profiling of tumors to identify effective treatments for diseases, broadening the scope of potential interventions and therapeutic approaches.
Career Highlights: Throughout his career, Daniel has held influential positions at reputable institutions, including Caris MPI, Inc. and The Translational Genomics Research Institute. His dedication to cancer research and innovation has made him a key figure in developing novel therapeutic strategies that have the potential to improve patient outcomes significantly.
Collaborations: Daniel's collaborative efforts with fellow researchers, such as Robert J. Penny and David M. Loesch, have fostered advancements in the field. These partnerships have not only propelled his work forward but have also contributed to a broader understanding of therapeutic strategies for complex cancers.
Conclusion: Daniel D. Von Hoff's innovative spirit and commitment to cancer research exemplify the vital role of inventors in healthcare advancements. His extensive patent portfolio and groundbreaking work in identifying effective treatments underscore his impact on transforming cancer therapy. As the field continues to evolve, the insights and inventions brought forth by Daniel will undoubtedly inspire future generations of researchers and innovators.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile